Onyx Pharmaceuticals, Inc. Says FDA Agrees on Blood Cancer Drug Trial Design

Reuters -- Onyx Pharmaceuticals Inc said it reached an agreement with the U.S. Food and Drug Administration on the design of the late-stage trial of its blood cancer drug.